Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview
Go back to Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 27.97 -0.05 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.02 | 52 Week High | $42.49 | |||
| Open | $27.63 | 52 Week Low | $16.64 | |||
| Day High | $28.09 | P/E | N/A | |||
| Day Low | $27.10 | EPS | $-0.42 | |||
| Volume | 665,202 | |||||
